Michael Pensiero

2.6k total citations
32 papers, 1.6k citations indexed

About

Michael Pensiero is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Michael Pensiero has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Virology and 9 papers in Infectious Diseases. Recurrent topics in Michael Pensiero's work include HIV Research and Treatment (11 papers), Virus-based gene therapy research (9 papers) and vaccines and immunoinformatics approaches (8 papers). Michael Pensiero is often cited by papers focused on HIV Research and Treatment (11 papers), Virus-based gene therapy research (9 papers) and vaccines and immunoinformatics approaches (8 papers). Michael Pensiero collaborates with scholars based in United States, Switzerland and South Africa. Michael Pensiero's co-authors include Carl W. Dieffenbach, Gabriela Dveksler, Kathryn V. Holmes, C B Cardellichio, J. Hay, G S Jiang, Richard K. Williams, John B. Sharefkin, K McCuaig and Susan F. Leitman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Journal of Virology.

In The Last Decade

Michael Pensiero

31 papers receiving 1.5k citations

Peers

Countries citing papers authored by Michael Pensiero

Since Specialization

Citations

This map shows the geographic impact of Michael Pensiero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pensiero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pensiero more than expected).

Fields of papers citing papers by Michael Pensiero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pensiero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pensiero. The network helps show where Michael Pensiero may publish in the future.

Co-authorship network of co-authors of Michael Pensiero

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pensiero. A scholar is included among the top collaborators of Michael Pensiero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pensiero. Michael Pensiero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119 2024 ·JCI Insight ·Spyros A. Kalams, Barbara K. Felber, James I. Mullins, Hyman Scott, Mary Allen, Stephen C. De Rosa, Jack Heptinstall, Georgia D. Tomaras, Jiani Hu, Allan C. deCamp, Margherita Rosati, Jenifer Bear, Michael Pensiero, John H. Eldridge, Michael A. Egan, Drew Hannaman, M. Juliana McElrath, George N. Pavlakis	3
2	Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1–uninfected adult participants in the US 2023 ·Vaccine ·Hong‐Van Tieu, Shelly Karuna, Yunda Huang, Magdalena E. Sobieszczyk, Hua Zheng, Georgia D. Tomaras, David C. Montefiori, (unknown), (unknown), Kristen W. Cohen, (unknown), (unknown), Jack Heptinstall, Kelly E. Seaton, Sheetal Sawant, (unknown), Michael Pensiero, Lawrence Corey, Katharine J. Bar	0
3	HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens 2020 ·Scientific Reports ·Xiaoying Shen, Fatima Laher, Zoe Moodie, (unknown), Rachel L. Spreng, Peter B. Gilbert, Ying Huang, Nicole L. Yates, Nicole Grunenberg, M. Juliana McElrath, Mary Allen, Michael Pensiero, Vijay Mehra, Olivier Van Der Meeren, Susan W. Barnett, Sanjay Phogat, Glenda Gray, Linda‐Gail Bekker, Lawrence Corey, Georgia D. Tomaras	9
4	Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period 2019 ·The Journal of Infectious Diseases ·Paul Spearman, Georgia D. Tomaras, David C. Montefiori, Ying Huang, Marnie Elizaga, Guido Ferrari, S. Munir Alam, Abby Isaacs, Hasan Ahmed, John Hural, M. Juliana McElrath, (unknown), Michael Pensiero, Christopher Butler, Spyros A. Kalams, Edgar T. Overton, Susan W. Barnett, (unknown)	4
5	Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015 2017 ·Vaccine ·Bruce G. Weniger, Ian E. Anglin, (unknown), Michael Pensiero, Jeffrey K. Pullen	5
6	Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: What are the “cGMP”? 2015 ·Vaccine ·Rebecca Sheets, (unknown), Jeffrey K. Pullen, Christopher Butler, Vijay Mehra, Stuart Z. Shapiro, Michael Pensiero	1
7	An HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected Adults 2014 ·AIDS Research and Human Retroviruses ·Christine M. Hay, Gregory J. Wilson, Marnie Elizaga, (unknown), Nidhi Kochar, Mary Allen, Magdalena E. Sobieszczyk, Ian Frank, Nicole Frahm, Georgia D. Tomaras, Michael A. Egan, Michael Pensiero, John H. Eldridge, (unknown)	1
8	Recent Advances in Humanized Mice: Accelerating the Development of an HIV Vaccine 2013 ·The Journal of Infectious Diseases ·Andrew M. Tager, Michael Pensiero, Todd M. Allen	14
9	Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype CgagVaccine in Healthy HIV-1-Uninfected Adults 2012 ·Clinical and Vaccine Immunology ·Margaret Wecker, Peter B. Gilbert, Nina D. Russell, John Hural, Mary Allen, Michael Pensiero, Jeffrey D. Chulay, Ya-Lin Chiu, Salim S. Abdool Karim, Donald S. Burke	50
10	Current advances and challenges in HIV-1 vaccines 2006 ·Current HIV/AIDS Reports ·Isaac R. Rodriguez‐Chavez, Mary Allen, Edgar L. Hill, Rebecca Sheets, Michael Pensiero, James A. Bradac, M. Patricia D’Souza	11
11	Breeding of retroviruses by DNA shuffling for improved stability and processing yields 2000 ·Nature Biotechnology ·Sharon K. Powell, Michele Kaloss, (unknown), (unknown), (unknown), Michael Pensiero, Edward Otto, Willem P.C. Stemmer, Nay-Wei Soong	71
12	Engraftment of Hematopoietic Progenitor Cells Transduced with the Fanconi Anemia Group C Gene (FANCC) 1999 ·Human Gene Therapy ·Johnson M. Liu, Sonnie Kim, Elizabeth J. Read, Makoto Futaki, Inderjeet Dokal, Charles S. Carter, Susan F. Leitman, Michael Pensiero, Neal S. Young, Christopher Walsh	97
13	Retroviral Transfer of the Glucocerebrosidase Gene into CD34+ Cells from Patients with Gaucher Disease: In Vivo Detection of Transduced Cells without Myeloablation 1998 ·Human Gene Therapy ·Cynthia E. Dunbar, Donald B. Kohn, Raphael Schiffmann, Norman W. Barton, Jan A. Nolta, Joan A. Esplin, Michael Pensiero, Zhifeng Long, (unknown), Robert Emmons, (unknown), Susan F. Leitman, (unknown), Charles W. Carter, Roscoe O. Brady, Stefán Karlsson	35
14	Retroviral Transfer of the Glucocerebrosidase Gene into CD34 ⁺ Cells from Patients with Gaucher Disease: In Vivo Detection of Transduced Cells without Myeloablation 1998 ·Human Gene Therapy ·Cynthia E. Dunbar, Donald B. Kohn, Raphael Schiffmann, Norman W. Barton, Jan A. Nolta, Joan A. Esplin, Michael Pensiero, Zhifeng Long, (unknown), Robert Emmons, (unknown), Susan F. Leitman, (unknown), Charles W. Carter, Roscoe O. Brady, Stefán Karlsson	145
15	Development of Amphotropic Murine Retrovirus Vectors Resistant to Inactivation by Human Serum 1996 ·Human Gene Therapy ·Michael Pensiero, Christian Wysocki, (unknown), Gary E. Kikuchi	51
16	Retroviral Mediated Transfer of the cDNA for Human Glucocerebrosidase into Hematopoietic Stem Cells of Patients with Gaucher Disease. A Phase I Study. National Institutes of Health, Bethesda, Maryland 1996 ·Human Gene Therapy ·Cynthia E. Dunbar, Donald B. Kohn, Stefan Karlsson, Norman W. Barton, Roscoe O. Brady, Michele Cottler‐Fox, Gay M. Crooks, Robert Emmons, Joan A. Esplin, Susan F. Leitman, Carl Lenarsky, Jan A. Nolta, Robertson Parkman, Michael Pensiero, (unknown), Paul Tolstoshev, Kenneth I. Weinberg	35
17	Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. 1993 ·Proceedings of the National Academy of Sciences ·Gabriela Dveksler, Michael Pensiero, Carl W. Dieffenbach, C B Cardellichio, (unknown), (unknown), Kathryn V. Holmes	98
18	The Hantaan virus M-segment glycoproteins G1 and G2 can be expressed independently 1992 ·Journal of Virology ·Michael Pensiero, J. Hay	46
19	A Possible Role for Glycoprotein gpV in the Pathogenesis of Varicella-Zoster Virus 1990 ·Advances in experimental medicine and biology ·Paul R. Kinchington, Paul D. Ling, Michael Pensiero, (unknown), John Hay, William T. Ruyechan	21
20	The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka) 1990 ·Journal of Virology ·Paul R. Kinchington, Paul D. Ling, Michael Pensiero, Bernard Moss, William T. Ruyechan, J. Hay	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact